Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients

Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients

ObjectivesLittle is known about how various treatments impact the progression of interstitial lung disease (ILD) in rheumatoid arthritis (RA) patients. Here, we compared ILD progression in RA patients treated with Janus kinase inhibitors (JAKi) or biological disease-modifying anti-rheumatic drugs (b...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shota Kurushima, Tomohiro Koga, Masataka Umeda, Naoki Iwamoto, Ritsuko Miyashita, Takatomo Tokito, Daisuke Okuno, Hirokazu Yura, Hiroshi Ishimoto, Takashi Kido, Noriho Sakamoto, Yukitaka Ueki, Hiroshi Mukae, Atsushi Kawakami
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Immunology
Subjects:	rheumatoid arthritis interstitial lung disease RA-ILD JAK inhibitors methotrexate epithelial-mesenchymal transition
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1501146/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Methotrexate Use in Rheumatoid Arthritis-Related Interstitial Lung Disease (RA–ILD): Is It Beneficial?
by: Basma Mohamed Awad Mahmoud, et al.
Published: (2024-07-01)

The impact of the COVID-19 pandemic on the profile of interstitial lung disease presenting to the pulmonary medicine department of a tertiary care center in western India
by: Unnati Desai, et al.
Published: (2025-03-01)

Some sage advice: A case report of sage burning causing interstitial lung disease
by: Jonathan Ayling-Smith, et al.
Published: (2025-07-01)

PENGARUH PENERAPAN INTERACTIVE LECTURE DEMONSTRATION (ILD) BERORIENTASI CONCEPTUAL CHANGETERHADAP PENINGKATAN PEMAHAMAN KONSEP SISWA SMP PADA MATERI HUKUM NEWTON
by: Yudi Kurniawan
Published: (2015-04-01)

Chest CT in Pulmonary Fibrosis: A Narrative Review of Imaging Patterns and Their Prognostic Significance
by: Mehrshad Dabbagh, et al.
Published: (2025-06-01)

Toll interacting protein gene polymorphisms in patients with systemic sclerosis: association with interstitial lung disease, outcome, and survival
by: Niels Schröder, et al.
Published: (2025-05-01)

Real-world data on home high-flow nasal cannula oxygen therapy in end-stage respiratory disease
by: Pedro Magalhães Ferreira, et al.
Published: (2025-02-01)

Comparison of rituximab vs. cyclophosphamide in rheumatoid arthritis-associated interstitial lung disease and its correlation with spirometry
by: Mohammed Abdullah Saleem, et al.
Published: (2024-12-01)

Case report: Exploring efficacy of tofacitinib in modulating interferon response in five case of anti-MDA5+ dermatomyositis with interstitial lung disease
by: Jie Zhao, et al.
Published: (2025-02-01)

The efficacy of trastuzumab deruxtecan in Chinese breast cancer patients: a real-world multicenter study
by: Miao He, et al.
Published: (2025-08-01)

Retrospective Evaluation of Tooth Agenesis in Different Regions of Turkey with Panoramic Radiography
by: Neşe Oral, et al.
Published: (2025-01-01)

Fibroblasts in rheumatoid arthritis: novel roles in joint inflammation and beyond
by: Elpida Neofotistou-Themeli, et al.
Published: (2025-01-01)

From Gut to Lung: The Role of Bile Acids in Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)
by: Shi YJ, et al.
Published: (2025-08-01)

FeNO as a biomarker of interstitial and fibrotic pulmonary sequelae in patients admitted for severe SARS-CoV-2 pneumonia
by: Diego Ferrer-Pargada, et al.
Published: (2025-07-01)

Anti-synthetase syndrome with anti-PL-7 antibody positive in a child: a case report and literature review
by: Jia Liu, et al.
Published: (2025-03-01)

Polydatin-curcumin formulation alleviates CTD-ILD-like lung injury in mice via GABBR/PI3K/AKT/TGF-β pathway
by: Zhengju Zhang, et al.
Published: (2025-06-01)

Connective Tissue Disease‑Associated Interstitial Lung Disease (CTD‑ILD)
by: Cindy Mai
Published: (2024-11-01)

Correction: Acute exacerbation of anti-Ha antibody-positive antisynthetase syndrome-associated interstitial lung disease: a case report
by: Yinying Li, et al.
Published: (2025-06-01)

A retrospective analysis of the relationship between dermatomyositis‐associated interstitial lung disease and disease duration, age, arterial blood gas pH, and serum Cl− levels
by: Xu Zhang, et al.
Published: (2024-09-01)

Inhibition of Matrix Metalloproteinase-7 Attenuates Subpleural Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease
by: Li Xiong, et al.
Published: (2025-06-01)

Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons
by: Giacomo Giulianelli, et al.
Published: (2025-05-01)

Acute exacerbation of anti-Ha antibody-positive antisynthetase syndrome-associated interstitial lung disease: a case report
by: Yinying Li, et al.
Published: (2025-06-01)

Integrating Radiomics Signature into Clinical Pathway for Patients with Progressive Pulmonary Fibrosis
by: Giacomo Sica, et al.
Published: (2025-01-01)

Outcomes with venoarterial vs venovenous extracorporeal membrane oxygenation as a bridge to lung transplantation in interstitial lung disease
by: Prasanth Balasubramanian, MD, et al.
Published: (2025-08-01)

Serum Lactate Dehydrogenase Levels Reflect the Lung Injury Extension in COVID‐19 Patients at Hospital Admission
by: Maria Sofia Bertilacchi, et al.
Published: (2025-03-01)

Immunological Features and Potential Biomarkers of Systemic Sclerosis–Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis
by: Shuai Shao, et al.
Published: (2025-04-01)

Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey
by: Emil Vilstrup Moen, et al.
Published: (2025-02-01)

Clinical Significance of Abnormal Serum LGALS3BP Expression in Patients with Idiopathic Inflammatory Myopathies
by: Huang L, et al.
Published: (2024-11-01)

Alveolar cell composition in interstitial lung disease and the development of a pulmonary progressive fibrosing phenotype: a retrospective cohort study
by: Iris A. Simons, et al.
Published: (2025-04-01)

Quantitative CT Assessment of Pulmonary Fibrosis Severity in Patients with Connective Tissue Disease-associated Interstitial Lung Disease
by: Ke WANG, et al.
Published: (2025-07-01)

Anti-melanoma differentiation-associated gene 5 antibody associated rapidly progressive interstitial lung disease in a pediatric patient: a case report
by: Thitima Sirimontakan, et al.
Published: (2025-06-01)

Segmentation and Classification of Interstitial Lung Diseases Based on Hybrid Deep Learning Network Model
by: Surendra Reddy Vinta, et al.
Published: (2024-01-01)

Case report: Pulmonary non-Langerhans cell histiocytosis in a dog with acute interstitial granulomatous pneumonia
by: Kyle L. Granger, et al.
Published: (2025-02-01)

Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis
by: Takahiro Takazono, et al.
Published: (2024-12-01)

Janus
by: Jean Marie Théodat
Published: (2010-01-01)

Refractory and Relapsing Laryngeal Edema Possibly Associated With Chronic Tonsillitis and Mycoplasma Infection, Requiring Reintubation and Tracheostomy
by: Yutaka Tsukamoto, et al.
Published: (2025-01-01)

Prognostic differences between pre-existing atrial fibrillation in chronic kidney disease and new-onset atrial fibrillation at hemodialysis initiation: a retrospective single-center cohort study.
by: Tomohisa Tsuyuki, et al.
Published: (2025-01-01)

Haemodynamics and post-exercise recovery response in COPD-PH and ILD-PH: An appraisal
by: Sayoni Sengupta, et al.
Published: (2025-05-01)

Almonertinib-induced interstitial lung disease in an NSCLC patient co-harboring EGFR Ex19del mutation and MET de novo amplification: a case report and literature review
by: Wenjing Yang, et al.
Published: (2025-02-01)

Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series
by: Maria Angela Licata, et al.
Published: (2025-04-01)